Drug or technology

Ketamine (0.5 mg/kg)

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · INTERVENTIONAL STUDY

Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress

ClinicalTrials.gov

This is an active pilot feasibility study with no results reported; the registry record describes planned enrollment of 8 participants and surrogate endpoints (ED time, survey scores) rather than clinical outcomes.

PreliminarySuicidal Suicidal Ideation Suicidal Ideation and Behavior

Reported

Estimated enrollment (dosing coho…8

Intervention dose0.5 mg/kg intramuscular ketamine

Primary outcome 1Difference in time spent in ED for dosing v…

SEP 3, 2026 · PHASE 2/3 TRIAL

Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression

ClinicalTrials.gov

This is a Phase 2/3 trial registration with no posted results; it describes a planned intervention combining ketamine and behavioral activation for treatment-resistant depression but carries no efficacy or safety data.

PreliminaryThe Royal's Institute of Mental Health Research Treatment Resistant Depression Behavioural Activation Therapy

Reported

Planned enrollment60

Primary outcome measureChange in MADRS from Baseline (Week 0) to e…

Ketamine dose0.5 mg/kg